Methods and compositions for reducing the impact of enteric diseases
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsMichael Roof, Marc Eichmeyer
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an immunogenic composition that comprises a PCV2 antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with an enteric infection, even more preferably, with enteric disease. The use relates to a method comprising the steps of administering the composition to an animal in need thereof, preferably prior to disease exposure. Administration of PCV2 antigen, preferably ORF2 of PCV2, lessens the incidence and reduces the severity of the enteric disease.
Claims21
A method of inducing an immunogenic response against an enteric pathogen comprising the step of:
- administering a composition comprised of a PCV2 antigen and a pharmaceutically acceptable carrier or adjuvant to an animal.
A method of lessening the incidence of enteric clinical signs of an enteric pathogen comprising the step of:
- administering a composition comprised of a PCV2 antigen and a pharmaceutically acceptable carrier or adjuvant to an animal.
A method of reducing the severity of clinical signs of enteric infection comprising the step of:
- administering a composition comprising a PCV2 antigen and a pharmaceutically acceptable carrier or adjuvant to an animal.
Dependencies are inferred from the claim text.